Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
Clinical trial NCT04964284 · UNKNOWN
Trial details
- NCT number
- NCT04964284
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2024-09-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.